RocketTickers

AcelRx announces FDA approval of DSUVIA(TM)

Long
NASDAQ:ACRX   None
ACRX: AcelRx Pharmaceuticals, Inc.
2018-11-02 13:56:00
AcelRx announces FDA approval of DSUVIA(TM)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.